Abstract:
ObjectiveTo investigate the effects of tirofiban combined with fasudil on the coagulation, fibrinolysis, inflammation and echocardiographic parameters in patients with acute myocardial infarction(AMI) after PCI.
MethodsA total of 206 AMI patients treated with PCI were selected, and divided into the observation group(n=103) and control group (n=103) by random number table.The control group was treated with tirofiban, and the observation group was treated with fasudil on the basis of the control group.The immediate postoperative thrombolysis in myocardial infarction(TIMI) grade, TIMI myocardial perfusion grade(TMPG), adverse reactions and major adverse cardiovascular events(MACE) after 3 months of surgery were compared between two groups.The thrombin fibrinolytic indexesincluding the thrombin time (PT), activated partial thrombin time(APTT), fibrinogen(FIB) and plasminogen activator inhibitor-1(PAI-1), inflammatory indexesincluding the tumor necrosis factor-α(TNF-α), interleukin-6(IL-6) and hypersensitive C-reactive protein(HS-CRP) were compared between two groups before operation, and after 3 d and 7 d of operation.The echocardiographic parametersincluding the left ventricular ejection fraction(LVEF), cardiac index(CI), left ventricular end diastolic diameter(LVEDD) and left ventricular end systolic diameter(LVESD) were compared between two groups before surgery and after 7 d of surgery.
ResultsThe immediate postoperative TIMI classification rate of grade 3 and rate of TMPG grade 3 in observation group were higher than those in control group(P < 0.05).After 3 d and 7 d of operation, the levels of PT and APTT increased, while the levels of FIB, PAI-1, TNF-α, IL-6 and hs-CRP decreased in two groups compared with before operation(P < 0.05), and which in observation group was better than that in control group(P < 0.01).After 7 d of operation, the levels of LVEF and CI in two groups increased, the levels of LVEDD and LVESD decreased compared with before operation(P < 0.05), and which in observation group were better than that in control group(P < 0.01).There was no statistical significance in the incidence of adverse reactions between two groups(P>0.05).The incidence of MACE in observation group was lower than that in control group after 3 months of operation(P < 0.05).
ConclusionsTirofiban combined with fasudil can improve the overall therapeutic effects of PCI, reduce the risk of MACE in AMI patients, and the safety is guaranteed.